Navigation Links
Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007,AACR Annual Meeting

obtain, maintain and enforce our own intellectual property; that development of TPI 287 is delayed or terminated because the costs of further development exceed its value; and that the Company's resources will be insufficient to continue development. Additional risks, uncertainties and other factors are identified under the captions "Risk Factors" and "Special Note Regarding Forward-Looking Statements" in the Company's reports filed from time to time with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 27, 2006. The Company disclaims any intention or obligation to update publicly or revise any forward-looking statements, whether as a result of new or additional information, future events or otherwise.

    Contact:   Tapestry Pharmaceuticals, Inc.

               Gordon Link

               Senior Vice President, Chief Financial Officer

               303-516-8500

               


               Elma Hawkins, Ph.D.

               Communications and Corporate Development

               212-400-3019

               


    Investor:  Lilian Stern

               Stern Investor Relations, Inc.

               212-362-1200

               


    Media:     Lloyd Benson/Dana Conti

               Schwartz Communications

               781-684-0770
glink@tapestrypharma.com ehawkins@tapestrypharma.com lilian@sternir.com tapestry@schwartz-pr.com

CONTACT: Gordon Link, Senior Vice President, Chief Financial Officer,+1-303-516-8500, , or Elma Hawkins, Ph.D.,Communications and Corporate Development, +1-212-400-3019,, both of Tapestry Pharmaceuticals, Inc., orLilian Stern, Stern Investor Relations, Inc., +1-212-362-1200,, or Lloyd
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tapestry Pharmaceuticals Present Data TPI the AACR Annual Meeting
(Date:5/15/2008)...in human clinical data highlight safety profile of... solid tumors -, BRISBANE, Calif., May 15 /PRNews...opharmaceutical company developing novel cancer th...lead PARP inhibitor, BSI-201, will,be presented at...nual,meeting in Chicago., Findings will be presen...
(Date:5/15/2008)...NE, Australia, May 15 /- Cy...abstract for its upcoming oral,presentation on CYT...iety,of Clinical Oncology (ASCO) will be accessibl...co.org ) from 9pm on Thursday 15 May (US EDT)., T... of CYT997, a novel,cytotoxic and vascular disrupt...
(Date:5/15/2008)...ure reductions demonstrated in Blacks, Hispanics/L...Obese Individuals, PARSIPPANY, N.J., May 15 /PRNe...hat data presented at the American Society of,Hype... (ASH 2008) in New,Orleans demonstrated that the p...olmesartan medoxomil) safely and effectively helpe...
(Date:5/15/2008)...OR, Mich. and TOULOUSE, France, May 15 /PRNewswire...y held pharmaceutical company,developing HDL-relat...nd,metabolic diseases, today announced that it has...ne of the company,s lead product candidates.,CER-0... (PPAR),delta-specific agonist in development for ...
Breaking Medicine Technology:BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Stopping a deadly killer 14706 1Stopping a deadly killer 14706 2Exploring the Aaah 241 Million Grant Advances Aquatic Health Research 14701 1Exploring the Aaah 241 Million Grant Advances Aquatic Health Research 14701 2International Diabetes Federation gives grant to UMDNJ University Hospital in Newark 14698 1International Diabetes Federation gives grant to UMDNJ University Hospital in Newark 14698 2International Diabetes Federation gives grant to UMDNJ University Hospital in Newark 14698 3Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 1Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 2Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen 28R 29 Technology at Lower Doses 1558 3
...Survival by 33% 3.5 Years Post Surgery, VIENNA, Va...CORPORATION announced today that its cancer drug M...ng term overall survival in a,Phase II study of he...ed on May 20, 2007 at the First International Cong...logy in Amsterdam, the,Netherlands, by Dr. Eyal Ta...
...th Medication Instructions but,Underscore Need for...ent and More Healthcare Provider Efforts to Contro.../PRNewswire/ -- Results of a survey,conducted by H...n,Foundation (HEF) were presented at the American ...Annual Scientific Meeting,and Exposition (ASH 2007...
Other Medicine Technology:CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 2CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 2Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 3Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 4Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 5Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 6Hypertension Education Foundation Survey Results Announced At,American Society For Hypertension Annual Meeting Suggests Improved,Control Of High Blood Pressure, But Misconceptions Still Exist 7
(Date:5/16/2008)...CH, Fla., May 16 /PRNewswire-USNewswire/- "Huh, wh... by Americans, particularly our,children. More tha..., have,significant hearing loss and the numbers ar...y 100 school age children have some form of hearin...social and economic problem,is what led Kathlyn Ma...
(Date:5/16/2008)...ents Urban Health Institute with 10,000 Sensual O ...g at Playboy Mansion Fundraiser, LOS ANGELES, May...p-hop,and R & B artist J Kwon known best for his h...l be presenting the Urban Health Institute (UHI) w...over $50,000. The donation is,being made to promot...
(Date:5/16/2008)...RG, Pa., May 16 /PRNewswire-USNewswire/ -- Emergen...tunity to highlight the dedication,of Pennsylvania... become,trained EMS volunteers, according to state...ar,s theme, "EMS: Your Life is Our Mission," empha... it occurs, EMS is there to provide,immediate, lif...
(Date:5/16/2008)...s for Funds Focus on Millions of Children Still in.... Fund for UNICEF and The,Advertising Council toda...e,a series of national public service announcement...en Stiller, Nicole Ritchie, Joel Madden, David,Duc...elp survivors of the,Myanmar cyclone. The Ad Counc...
Breaking Medicine News(10 mins):Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3Health News:Everybody in the Club Scream O! 2Health News:PA Secretary of Health Announces 'Emergency Medical Services Week,' May 18 - 24 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3
... the recent communiqué from US drug reviewers, the...to contain the HIV virus when used in combination ...ed as maraviroc may find a prominent place amongst...o impede the CCR5 co-receptor, the main route for ...
... bowel disease may also be at risk for developing ...rding to a research. // Inflammatory bowel disease...olitis and Crohn’s disease that cause swelling and...e study, researchers compared 103 people with Croh...
...und that infection with HIV, the virus that causes...yocardial infarction or heart attack.// While rate... increased in study participants infected with HIV...tack was beyond what could be explained by risk fa...
...has launched a seven-day camp in this Taj Mahal ci...sex and other licentious activities.// Ram Dev, wh...he was opposed to sex education being given to the...nced and disciplined lifestyle is what we need (fo...
Other Medicine News:Health News:HIV Infection Associated With Increased Risk of Heart Attack 2
Slim Line Flowmeters with brass and aluminum body., ,Options: , For security chain, add suffix S to model number. Example: FME107S. , For Canadian Color-Code, add suffix C to model number. Example:
FM Series Oxygen Adult Flowmeters, ,Options: , For security chain, add suffix S to model number. Example: FM107S. , For Canadian Color-Code, add suffix C to model number. Example: FM104C. , For Doub
... the professional ophthalmic photographer. Integra...t and background illumination, all controlled thro...t lamp joystick, as well as adaptors allowing for ...level digital and 35 mm cameras, ensure ophthalmic...
...ing, blood sampling, and administration of drugs a...ffer:, , , Higher Flow Rates, Micropunct...ne Material, , ,Catheter may be trimmed to p... prior to trimming of catheter. Supplied sterile i...
Medicine Products: